Pharmaceuticals

What the AGP acquisition and restructuring means for Pakistani pharma

Cabinet approves nationwide track-and-trace system for medicines

Pakistani pharma company secures PIC/S certification for sterile medicines facility

AGP Limited approves major pharma merger plan expected to raise revenue to ₨37.5 billion

DRAP fixes retail prices of 35 life-saving medicines

Pakistan, Chinese firms sign 10 MoUs for pharmaceutical investment, API production

As revenue rise among pharma companies, competition for market share heats up

Govt fixes prices for 35 life-saving medicines, 45 more under review

Profits among listed pharma companies surge to record $150 million

Russian firm to invest $80 million in Pakistan for insulin manufacturing

DRAP denies reports of medicine price hike, says supplies stable

Hoechst Pakistan board approves evaluation of expansion, acquisition options

DRAP advises pharma firms to diversify raw material sources amid global supply concerns

Iran war disrupts pharmaceutical raw material supply chain, Pakistan stocks may last two months

Deregulated pricing, low-cost Chinese APIs quadrupled Pakistan’s pharma profits: report

For GSK, declining costs boost margins as much as rising prices

Haleon investing heavily in Jamshoro factory expansion for exports

Amoxil recall hits GSK Pakistan revenue in otherwise strong year

123...7Next